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Genotoxicity, Carcinogenicity, and Mode of
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Charles A. Lovelette,*t Charles Tong,* Takuji Tanaka,*§
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Because mutagens typified by 2-amino-3-methylimidazo[4,5-flquinoline (IQ) observed in cooked foods
are widely consumed, detailed studies of their biochemical and biological properties including carcino-
genicity are most important. IQ induces unscheduled DNA synthesis in liver cells, which when taken
together with its powerful mutagenicity in the Salmonella typhimurium test system, predicts carcinogen-
icity. In female Sprague-Dawley rats, IQ did exhibit potent carcinogenicity for the mammary gland, the
ear duct, and to a lesser extent, pancreas and bladder. Data from Japanese laboratories indicate carcin-
ogenicity also to the intestinal tract. Thus, one of the mutagens formed during cooking is a versatile
carcinogen that because ofextensive human intake requires urgent exploration for specific human cancer
risk.
Introduction
The discovery by Sugimura et al. (1,2) that the sur-
faces of fried meat or fish contain powerful mutagens
opened an important new area in food toxicology and
nutritional carcinogenesis. Isolation of these mutagens
identified them as heterocyclic aromatic compounds
with an exocyclic amino group and often an o-methyl
group (3). This newly discovered class ofmutagens may
be the as yet unknown carcinogens for the nutritionally
linked cancers (4). Thus, it is important to acquire de-
tailed information on their biological properties and
their mode of action.
Inspection of the structures of the food mutagen 2-
amino-3-methylimidazo[4,5-flquinoline (IQ), the syn-
thetic chemical 3,2'-dimethyl-4-aminobiphenyl (DMAB)
(a carcinogen for the colon, breast, and prostate), and
quinoline shows that IQ contains both the quinoline ring
system and the primary amine with an o-methyl sub-
stituent, which characterizes DMAB. Since IQ is both
a mutagen and a carcinogen, it is important to establish
whether this compound is activated by oxidation ofthe
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amino group or whether ring epoxidation, such as may
occur with quinoline, is also relevant.
Experiments presented here demonstrate that IQ,
one of the mutagens found in fried meat, is not only a
powerful mutagen in the Ames Salmonella typhimu-
riumtest systembut can also induce unscheduled DNA
synthesis (UDS) in the primary culture rat hepatocyte
(HPC) test ofWilliams. Also, although quinoline can act
as an initiator in carcinogenicity tests on the skin ofWEISBURGER ET AL.
mice promoted with phorbol ester, IQ fails to act as an
initiating agent, and the homocyclic analog 3,2'-di-
methyl-4-aminobiphenyl likewise appears negative as
an initiator. Furthermore, in tests ofthe mutagenicity
of analogs of IQ, only the chemicals with an exocyclic
amino group had powerful activity. It seems likely that
mutagenicity and other reactions involving attack on
DNArequiretheN-oxidationofexocyclicaminogroups.
Ringepoxidation isprobablynotalikelyactivation step.
Any compound active as a mutagen in the Ames test
and capable of inducing DNA repair in the Williams
HPC test is likely to be a carcinogen (5). We now find
this prediction verified. IQ is a potent carcinogen for
the rat mammary gland in comparison to an established
positive control carcinogen for this organ, 4-aminobi-
phenyl(4-AB). Also, IQinducedZymbal'sglandtumors,
and to a lesser extent, neoplastic nodules, carcinomas
andhemangioendotheliomas intheliver, pancreaticneo-
plasms, andrenalpelvis andurinarybladderneoplasms.
Furthermore, preneoplastic lesions were seen in the
liver, pancreas, and adrenal cortex. Thus, IQ is a mul-
tipotent carcinogen for the rat by affecting a variety of
target organs. These data together with those obtained
by Ohgaki et al. (6,7) and Takayama et al. (8,9) suggest
that specific modes of cooking lead to carcinogens in
mice and rats ofseveral strains that exhibit an organo-
tropism simulating that seen in the nutritionally linked
cancers in the Western World.
Materials and Methods
Chemicals and Media
Gold-label (99% pure) quinoline was purchased from
Aldrich Chemical Co. (Milwaukee, WI) and redistilled
prior to use. Purity established by gas chromatography
was greater than 98%. DMAB was purchased as the
hydrochloride saltfromAsh-Stevens (Detroit, MI). The
free base was obtained by extraction from a saturated
solution of sodium bicarbonate into diethyl ether. Ex-
tracted DMAB was eluted through a Clin Elut dispos-
able column (FisherScientific, Pittsburgh, PA), and sol-
vent wasremoved byrotaryevaporation. Noimpurities
were detectable by HPLC; the correct mass spectrum
completed structural identification. IQ was purchased
from Toronto Research Chemicals, Toronto, Canada
(Dr. David Dime). No impurities were detectable by
HPLC; the compound had the correct mass spectrum
(10).
4-AB was purchased from Aldrich Chemicals (Mil-
waukee, WI). For the carcinogenicity tests, IQ and 4-
AB were converted to the hydrochloride salt by using
an excess ofgaseous HCl in methanol. The product was
then filtered, washed with cold ethanol and ether, and
stored at 4°C until used.
12-O-Tetradecanoylphorbol-13-acetate (TPA) was
purchased from Consolidated Midland (Brewster, NY).
Williams' Medium E (WME) and calfserum were ob-
tained from Flow Laboratories (Rockville, MD).
[3H]TdR, 60-80 Ci/mmole, was purchased from New
England Nuclear (Boston, MA). NTB, D19 developer,
and fixer were from Eastman Kodak (Rochester, NY).
MediaforbacterialmutagenicityassayswerefromDifco
Laboratories (Detroit, MI). NADP and glucose-6-phos-
phate were from Sigma Chemical Co. (St. Louis, MO).
Preparation of Imidazoquinoline
Derivatives
2-Amino-lH[3H]imadazo[4,5-flquinoline was pre-
paredinthefollowingfashion. 5-Amino-6-nitroquinoline
(Aldrich) was reduced with tin(II)chloride and concen-
trated hydrochloric acid followed by appropriate
workup to 5,6-diaminoquinoline (11,13), which was
treated with cyanogen bromide in refluxing methanol,
bringing about final closure of the imidazole ring. 5,6-
Diaminoquinoline served as the key precursor in the
preparation of 1H[3H]imidazo[4,5-flquinoline and 2-
methyl-lH[3H]imidazo[4,5-f]quinoline where final ring
closure was accomplished by reflux in the appropriate
acid. 3-Methyl-imidazo[4,5-f]quinoline was prepared by
a slight modification ofthe method ofMyers and Zelez-
nick (14), which involved lyophilization of
1H[3H]imidazo[4,5-f]quinoline and tetramethylammon-
ium hydroxide (10% aqueous) followed by sublimation
of the final product at 200°C and and 0.5 torr. Proton
NMR spectral data indicate that N-3 alkylation pre-
dominates over N-1 substitution (15). The purity of all
compounds described above was established by TLC
(silica, methylene chloride, ethyl acetate, 1:1 V/V, and
hexane, methyl alcohol 9:1 V/V). Final purification was
accomplished by preparative layer chromatography
techniques, ifrequired.
Mutagenicity Assay
Salmonella typhimurium tester strains TA 98 and
TA 100 were obtained from B. N. Ames (16,17). The
S9 fraction of liver was prepared from male Sprague-
Dawley rats induced with Aroclor 1254 (17). Each assay
involved 100 puL of an overnight culture of bacteria
added to 2 mL of soft agar containing histidine and
biotin, and 0.5 mL of S9 mix containing 50 ,uL of S9
fraction (40 mg protein/mL). The test compounds were
dissolved with 100 ,uL ofDMSO. The mixture was vor-
texed and overlaid onto Vogel-Bonner minimal agar
plates, then incubated for 48 hr at 37°C and counted on
an Artek Model 880 colony counter. Controls included
vehicle control, positive control (2-aminoanthracene for
both TA 98 and TA 100), and sterility controls contain-
ing soft agar + test agent, soft agar + S9 mix, and
soft agar alone. Spontaneous revertant frequencies in
this series of experiments were 40 + 9/plate with S9
for TA 98 140 + 15/plate with S9 for TA 100. Rever-
tant/nmole ofcompound andrevertants/,ugofcompound
werecalculatedbylinearregressionanalysisofthedata,
withoutsubtractingspontaneousrevertantfrequencies.
Assay for UDS in Rat HPC
Hepatocyte Preparation. The livers of adult rats
wereperfusedinsituwithcollagenase asdescribed(18).
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Preparations with acell viabilitygreaterthan85% were
used. About 5 x 105 viable cells were plated in a Linbro
dish(Flow Laboratories, Rockville, MD), witheachwell
containing a 25-mm2 round Thermox plastic coverslip.
The cells were allowed to attach for 2 hr in WME con-
taining 10% calf serum in a 5% CO2 incubator, then
washed and refed with WME.
HPCIDNA Repair Test. Immediately after the 2-
hr attachment period, hepatocytes were simultaneously
exposed to [3H]TdR (10 ,Ci/mL) andthetest compound
dissolved in DMSO. The maximum concentration of
DMSO was 1%. After 18 hr, the coverslips were pro-
cessed as previously described (18). Air dried cover-
slips, mounted on glass slides, were dipped in NTB
emulsion, then developed and stained after 10 days (18).
Nuclear and background grain counts were determined
with an Artek Model 880 counter using the area mode.
Three cytoplasmic counts were obtained for each nu-
cleus. Net nuclear counts were calculated by subtract-
ingthehighestcytoplasmic countfromthenuclearcount
for each cell. The data are expressed as the mean net
nuclear countforthree slides ± the standard deviation.
A net nuclear count of 5 grains or more represents a
positive response (18).
Bioassay for Initiating Activity on Skin of
Sencar Mice
Female mice, aged 49-51 days, were purchased from
Sprague-Dawley (Indianapolis, IN). A solution of 6
mmole of chemical was applied to the shaved backs of
mice in 0.1 mL of DMSO three times per week for 2
weeks. Ten days later the promoting regimen was ap-
plied as 2.1 mg TPA in 0.1 mL acetone twice a week
for20weeks. Twenty animals were treatedwith vehicle
only, 20withquinoline, and30 eachwith IQand DMAB.
The mice were examined weekly and papillomas were
scored when they reached a size of 7 mm in diameter.
Representative samples of gross tumors were submit-
ted for pathological examination.
Carcinogen Bioassay in Female Rats
Weanling female Sprague-Dawley rats (Sprague
Dawley, Madison, WI) were maintained in quarantine
for 2 weeks while routine health tests were performed.
At 6 weeks ofage, a total of 100 rats found suitable for
bioassay were transferred to holding rooms of the Re-
search Animal Facility, randomized into groups of 32
each experimental rats, 27 vehicle control rats, and 9
untreated control rats, and were kept three to a poly-
carbonate cage with hardwood bedding. The rooms
weremaintained at23 ± 2°C and40-60% humiditywith
8 to 10 air changes per hour and with a 12-hr light/dark
cycle. Drinking water (tap) was provided by an auto-
matic distribution system.
During the quarantine period, all rats were fed the
standard NIH-07 diet ad libitum. At 6 weeks of age,
beginning with the chemical treatment period, all rats,
including controls, were switched to a diet consisting of
standard NIH-07 to which 15% corn oil was added for
a total fat content of20% by weight.
The hydrochloride salts of IQ and 4-AB were dis-
solved in a solution of 5% Emulphor (EL 620, GAF
Corp., New York) in distilled water at a concentration
suchthat0.4mmole/kgbodyweightofIQor0.22mmole/
kg of 4-AB were present in 0.25 mL solutions. These
solutions were administered by gavage on the following
regimens. The first doses were given to rats when they
were 6 weeks old and continued three times per week
for weeks 1-4, at a time when the female Sprague-
Dawley rat is maximally sensitive to the induction of
mammary tumors. However, because ofbeginning tox-
icity, the three times per week treatment for 4-AB was
administered onlyfromweeks 1 to3. ForIQ, thegavage
was continued at two times per week from weeks 5 to
8, and for 4-AB, this protocol was used from weeks 4
to 8. For the next 23 weeks, the dosage was adminis-
tered once a week. After that time, all of the animals
continued without further chemical treatment on the
control diet. One group of rats was given the vehicle
control, 0.25 mL 5% Emulphor solution in distilled
water on the same schedule as the IQ group. An ad-
ditional group ofnine rats served as untreated controls.
Beginning 8 weeks after the first gavage treatment,
the animals were carefullypalpated to detectmammary
tumors (19). All rats were killed 52weeks afterthe first
dose. They were necropsied, any abnormalities were
noted, including the multiplicity oftumors. The tissues
were fixed in 10% buffered formalin and sections were
routinely prepared and stained for microscopic diag-
nosis. Histologically, mammary tumors were diagnosed
according to the classification of Young and Hallows
(20). Liverneoplasmswere diagnosed asneoplasticnod-
ules, hepatocellular carcinomas, or hemangioendothe-
liomas according to the criteria described by Stewart
et al. (21).
Results
Mutagenicity Tests of IQ Analogs
In comparison to the powerful mutagenic effect ofIQ
in the frameshift-sensitive Salmonella typhimurium
TA 98 strain and the lower degree of activity in the
base-pairing indicator ofthe Salmonella typhimurium
TA 100 strain, the chemical without a methyl substi-
tution had much lower activity in the TA 98 organism
and none at all in TA 100 (Table 1) (22). The compound
withouttheexocyclic aminogroupbutwithanN-methyl
substitution had a small but definite activity both in the
base-pairingandframeshiftsensitivetesterstrains. The
other compounds had no activity.
Assay for Unscheduled DNA Synthesis
(UDS)
A dose level of 1.25 x 10-3 M of IQ is toxic to the
liver cells (Table 2). Concentrations of 1.25 x 10' M
and 1.25 x 106 M elicited powerful DNA repair, to a
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Table 1. Mutagenicity of IQ and its derivatives in Salmonella typhimurium.a
TA 98 TA 100
Revertants/plateb Revertants/nmolec Revertants/plate Revertants/nmolec
I (IQ) R = NH2; R' = CH3 680/0.003 55,000 800/0.10 1,500
II R = NH2; R' = H 440/0.10 790 0 0
III R = H; R' =CH3 430/1000 0.08 390/250 0.30
IV R = CH3; R' = H 0 0 0 0
V R = H; R' = H 0 0 0 0
aS9 mix was present. From Barnes et al. (22).
bRevertants per plate/mass compound per plate (,ug).
'Calculated by linear regression analysis from the linear portion of the dose-response curve.
greater extent than an equivalent level ofDMAB. Even
aconcentration of1.25 x 10-7M waspositive. Quinoline
was weakly positive and exhibited 15 grains/nucleus at
the fairly high concentration of 1.0 x 10' M.
Initiating Activity on the Skin of SENCAR
Mice
In a test series conducted by LaVoie et al. (23) in this
Institute, quinoline was applied in acetone solution to
the skin of SENCAR mice. After 20 weeks, 13 of 20
animals (65%) had papillomas, and there were a total of
19 tumors. The current experiment utilized similar pro-
tocols and was performed at the same time with the
same shipment of mice. However, because of the rela-
tive insolubility of IQ in acetone, this test was per-
formed with all chemicals applied as solutions in DMSO.
Underthese conditions, quinoline initiationyielded skin
tumors in 70% of animals, and a total of 27 papillomas
in 20 animals (Fig. 1) (22). Thus, the DMSO solution of
quinoline gave a higher tumor yield compared to the
acetone solution. On the other hand, IQ and, interest-
ingly, DMAB did not act as initiators on mouse skin in
this sensitive system, both as regards the number of
tumor-bearing animals or the tumor multiplicity.
Carcinogen Bioassay in Female Sprague-
Dawley Rats
At the beginning of the test, the average weight of
all rats was 126 g. At week 10, group 1 (untreated)
weighed an average of 270 g; group 2 (vehicle), 274 g;
group 3 (IQ), 256 g; and group 4 (4-AB), 247 g. At week
31, at the end ofthe treatment, the weights were 371,
389, 343, and 347 g, respectively. Thus, the groups
given IQ or4-AB gained less weight by about 10% com-
pared to controls, indicating that the dosage adminis-
tered was consistent with proper toxicologic practice.
In the early weeks of the tests, the rats given 4-AB,
but not those on IQ, turned blue for some hours after
each gavage, suggesting an effect on the hematopoietic
system. This observation was made even though the
dose rate for 4-AB (0.22 mmole/kg) was about one-half
Table 2. Unscheduled DNA synthesis in primary explant
cultures of hepatocytes from F344 male rats exposed to IQ and
DMAB.a
DNA repair
% positive
Chemical Concentration, M Grains/nucleus nucleib
IQ 1.25 x 10-3 toxic
1.25 x 10-4 9.7 ± 3 48
1.25 x 10-5 130 ± 21 98
1.25 x 10-6 150 ± 18 97
1.25 x 10-7 12 + 8 37
DMAB 1.0 x 10-6 85 ± 27
aFrom Barnes et al. (22).
bPositive response = > 5 grains/nucleus.
that of IQ (0.4 mmole/kg). Survival in all groups was
good, since 97/100 rats were alive at 6 months. How-
ever, three to five rats in the groups receiving IQ or 4-
AB died or had to be killed each subsequent month
because of the occurrence of cancers, especially in the
mammary gland or ear duct. In all groups, 78 of the
starting 100 rats were alive when the test was termi-
nated at 52 weeks.
Neoplasms in the Mammary Gland. The major
finding in this bioassay was the induction of cancer in
the mammary gland. With IQ, the first palpable tumor
was noted during the 12th experimental week and with
the positive control carcinogen 4-AB during week 16.
Progressively more mammary tumors were palpated
during the test. No regression of palpable tumors was
noted. At the end ofthe 5-week study period, 14 ofthe
32 rats given IQ exhibited 21 mammary carcinomas and
one ahemangioendothelioma(Table3) (24). Inthe group
of32 rats given 4-AB, 18 had 32 mammary carcinomas,
2 had fibroadenomas, and 1 a fibrosarcoma. In the 27
control rats intubated with vehicle, 2 had three mam-
mary fibroadenomas. None of the nine untreated con-
trols had palpable or microscopic mammary gland tu-
mors.
Zymbal's Gland Neoplasms. Eleven of the thirty-
two rats given IQ had 12 keratinizing epidermoid car-
cinomas in the ear duct (Table 3). The earliest growth
appeared at 40 weeks. One animal had bilateral tumors.
The right ear duct was involved in 6/10 tumors. This
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Table 3. Incidence oftumors in female Sprague-Dawley rats treated with IQ or 4-AB.a
No. of animals
rats Mammary tumors Liver tumorsb Ear
No. of with Carci- Fibro- duct Other
Group Treatment rats tumors Total noma adenoma Others Total NN HC Others tumors tumors
1 Control 9 0 0 0 0 0 0 0 0 0 0 0
2 Vehicle control 27 2 2 0 2 0 0 0 0 0 0 0
(3) (3)
3 IQ 32 23* 14* 14* 0 ic 6* 3 2 2c 11* 5d
(22) (21) (1) (9) (5) (2) (2) (12) (6)
4 4-AB 32 20* 19* 18* 2 le 0 0 0 0 0 0
(35) (32) (2) (1)
aNumbers in parentheses are the total number oftumors. From Tanaka et al. (24).
bNN: neoplastic nodule, HC: hepatocellula carcinoma.
eHemangioendothelioma.
dGranulocytic leukemia, two rats: pancreatic acinar cell adenoma, one rat: islet cell adenoma, one rat: transitional cell papillomas ofpelvis
and urinary bladder, one rat.
eFibrosarcoma.
*Significantly different from Group 2 by Fisher's exact probability test (p < 0.05).
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FIGURE 1. Weekly incidence oftotal skin tumors on animals treated
withquinoline, IQ, DMAB, andvehicle (DMSO). Thetotalnumber
of tumors per animal was: quinoline 17/20, IQ 2/30, DMAB 5/30,
and vehicle 1/30. The number oftumorbearinganimals was: quin-
oline 70%, IQ 7%, DMAB 17%, and vehicle 3% (22).
lesion was absent in rats given 4-AB or either of the
two control groups.
Miscellaneous Preneoplastic or Neoplastic Le-
sions. In the IQ group, 17/32 rats had altered liver
cellfoci (Table 4), three had five neoplasticnodules, two
had hepatocellular carcinomas, and two more had he-
mangioendotheliomas in the liver (Table 3). With 4-AB,
5/32 had altered liver cell foci but no liver neoplasms
(Tables 3 and 4). The controls had normal livers.
In the IQ group, 19/32 had atypical hyperplastic aci-
nar cell lesions in the pancreas, one had an acinar cell
adenoma, and one had an islet cell adenoma ofthe pan-
Table 4. Incidence of preneoplastic lesions in female Sprague-
Dawley rats.a
No. of rats with preneoplastic lesions
Group 2,
Group 1, vehicle
control control
Group 3,
IQ
Group 4,
4-AB
Liver: altered liver cell foci 0 0 17* 5*
(53) (16)
Pancreas: atypical 0 0 19* 7*
hyperplastic acinar cell (59) (22)
lesions
Adrenal cortex: altered 0 0 5* 2
proliferative foci (16) (6)
aFrom Tanaka et al. (24). Numbers in parentheses are % oflesion-
bearing rats.
*Significantly different from Group 2 by Fisher's exact probability
test (p < 0.05).
creas (Tables 3 and4). With4-AB, only7/32hadatypical
hyperplastic acinar cell lesions but failed to show neo-
plasia in the pancreas.
With IQ, five altered proliferative foci in the adrenal
cortexwereseen, andthereweretwointhegroupgiven
4-AB (Table 4). In addition, in the group of rats given
IQ, two had leukemia and one had a papilloma of the
pelvis andurinarybladder(Table3). None ofthecontrol
or vehicle control rats had abnormalities in these or-
gans.
Discussion
IQ, one oftheimportantnewmutagensfound infried,
broiled, or cooked meat or fish, was a good inducer of
unscheduled DNA synthesis in liver cells. We have ob-
served that a chemical that is reliably active in both the
bacterial mutagenicity screen of Ames and the mam-
malian DNA repair system ofWilliams is most likely a
genotoxic carcinogen. The data presented indicate IQ
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to be quite active in both tests classifying it as- a geno-
toxic carcinogen (5,25).
On the other hand, the results ofthe assay for initi-
atingpotential onmouse skin, incontrasttothe positive
control quinoline, show that IQ and the related homo-
cyclic aromatic amine DMAB cannot act as initiators in
the skin ofthe sensitive SENCAR mouse strain, prob-
ably because the reactive electrophilic metabolites do
not reach the skin in sufficient amount under the con-
ditions of this test. In contrast, chronic feeding of the
carcinogenic aromatic amine 2-acetylaminofluorene
(AAF) revealed initiating potential onmouse skin when
followed by promotion by croton oil (26), or by subcu-
taneous injection of carrageenan in rats (27). Interest-
ingly, a higher incidence of skin tumors was obtained,
upon promotion with croton oil in mice fed with AAF
than in mice fed with its N-hydroxy derivative, the
proximate carcinogen (28). The N-hydroxy derivative,
normally considered more reactive, was less active (28),
and thus, the initiating action might stem from ring
epoxidation rather than N-oxidation. With quinoline it-
self, LaVoie et al. (29) noted that the 5,6-epoxide is a
possible carcinogenic form. In IQ, the imidazole ring
occupies the 5,6-region, which may account for the fail-
ure of IQ to act as an initiator.
The combined data obtained, therefore, suggest that
IQ and related heterocyclic mutagens and carcinogens
most likely are converted to proximate and ultimate
carcinogenic forms by N-oxidation on the exocyclic
amino group. The results of the mutagenicity test of
typical chemicals in this series point in the same direc-
tion. Furthermore, the metabolism experiments so far
reported indicate that N-hydroxylation is an essential
activation reaction (30).
In agreement with the positive results from the bat-
tery of in vitro tests described herein and elsewhere
(3,31-35), IQ has been found to be a multipotential,
powerful carcinogen in the rat. In this test, the chem-
icals were administered by gavage to obtain quantita-
tive information ofdosage and also to use the expensive
chemical IQ most economically. The total dosage ad-
ministered per rat was 4.4 mmole (871 mg) of IQ and
2.4 mmole (400 mg) of 4-AB, the positive control car-
cinogen. The overall duration of the test was 1 year.
Thus, with intermittent, limited administration of the
test chemical, a high yield of mammary gland cancer
was induced. In addition, other neoplasms were found,
including those in the ear duct, and to a lesser extent,
in the liver, pancreas, and urinary tract. Compared to
the positive control, the human carcinogen 4-AB, IQ
can be considered to have approximately the same po-
tency allowing for the 2-fold lower level of 4-AB ad-
ministered. Nonetheless, IQ demonstrated a greater
versatility, and yet specificity, by inducing cancer
mainly in the mammary gland and ear duct. The induc-
tion of mammary gland neoplasms may have been po-
tentiated by dietary fat as has been noted with other
mammary carcinogens, especially the closely related
homocyclic 3,2'-dimethyl-4-aminobiphenyl (36). In ad-
dition, Takayama et al. (7,8) observed the induction of
cancer in the intestinal tract, including small and large
intestines aswellaslesions inthepancreas and earduct,
when 300 ppm IQ was fed in the diet to Fischer strain
rats.
The data available thus far suggest that IQ, one of
the mutagens formed during the cooking of foods is a
potent carcinogen in mice and in rats of two strains.
Because IQ affected those target organs, intestional
tract, breast, and pancreas, among others, that rep-
resentthemainnutritionallylinked cancersintheWest-
ern World, it is important to extend these findings and
determine whetherthe mutagens foundinfried food are
the genotoxic carcinogens associated with major forms
of human cancer (37).
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